245 related articles for article (PubMed ID: 12826774)
21. An evidence-based approach to the management of pulmonary arterial hypertension.
Archer SL; Michelakis ED
Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
[TBL] [Abstract][Full Text] [Related]
22. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
[TBL] [Abstract][Full Text] [Related]
23. Advances in the treatment of secondary pulmonary hypertension.
Maloney JP
Curr Opin Pulm Med; 2003 Mar; 9(2):139-43. PubMed ID: 12574694
[TBL] [Abstract][Full Text] [Related]
24. Current medical treatment of pulmonary arterial hypertension.
Sulica R; Poon M
Mt Sinai J Med; 2004 Mar; 71(2):103-14. PubMed ID: 15029402
[TBL] [Abstract][Full Text] [Related]
25. [Disorders of pulmonary circulation].
Ogawa K; Sugioka K; Yoshiyama M
Nihon Rinsho; 2007 May; 65 Suppl 5():383-8. PubMed ID: 17571410
[No Abstract] [Full Text] [Related]
26. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation.
Chen YF; Jowett S; Barton P; Malottki K; Hyde C; Gibbs JS; Pepke-Zaba J; Fry-Smith A; Roberts J; Moore D
Health Technol Assess; 2009 Oct; 13(49):1-320. PubMed ID: 19863849
[TBL] [Abstract][Full Text] [Related]
27. Bosentan improves exercise tolerance and Tei index in patients with pulmonary hypertension and prostanoid therapy.
Seyfarth HJ; Pankau H; Hammerschmidt S; Schauer J; Wirtz H; Winkler J
Chest; 2005 Aug; 128(2):709-13. PubMed ID: 16100158
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary arterial hypertension in children.
Widlitz A; Barst RJ
Eur Respir J; 2003 Jan; 21(1):155-76. PubMed ID: 12570125
[TBL] [Abstract][Full Text] [Related]
29. [Pulmonary hypertension and right ventricular failure. Part IX. Traditional therapy of primary pulmonary arterial hypertension].
Batyraliev TA; Makhmutkhodzhaev SA; Pataraia SA; Ekinci E; Pershukov IV; Sidorenko BA; Preobrazhenskiĭ DV
Kardiologiia; 2007; 47(4):74-82. PubMed ID: 18260847
[TBL] [Abstract][Full Text] [Related]
30. [Treatments for pulmonary arterial hypertension].
Montani D; Jaïs X; Ioos V; Sitbon O; Simonneau G; Humbert M
Rev Med Interne; 2004 Oct; 25(10):720-31. PubMed ID: 15471598
[TBL] [Abstract][Full Text] [Related]
31. [Pulmonary hypertension in hereditary haemorrhagic teleangiectasia (Rendu-Osler-Weber disease). Progression over 10 years].
Schlag K; Opitz C; Wensel R; Felix S; Ewert R
Dtsch Med Wochenschr; 2005 Jun; 130(23):1434-7. PubMed ID: 15929019
[TBL] [Abstract][Full Text] [Related]
32. [Pulmonary arterial hypertension].
Jaïs X; Sitbon O; Savale L; Montani D; Humbert M; Simonneau G
Rev Prat; 2008 Nov; 58(18):1997-2010. PubMed ID: 19143271
[TBL] [Abstract][Full Text] [Related]
33. Recognition and management of pulmonary hypertension.
Wanstall JC; Jeffery TK
Drugs; 1998 Dec; 56(6):989-1007. PubMed ID: 9878988
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in the treatment of pediatric pulmonary artery hypertension.
Barst RJ
Pediatr Clin North Am; 1999 Apr; 46(2):331-45. PubMed ID: 10218078
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary hypertension: work in progress.
Boyce PD; Waxman AB
J Nucl Cardiol; 2003; 10(4):413-23. PubMed ID: 12900746
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary hypertension: pathogenesis and management.
Nyamande K
Cent Afr J Med; 2006; 52(1-2):20-4. PubMed ID: 17892236
[TBL] [Abstract][Full Text] [Related]
37. Prostacyclin therapy for pulmonary arterial hypertension.
Ruan CH; Dixon RA; Willerson JT; Ruan KH
Tex Heart Inst J; 2010; 37(4):391-9. PubMed ID: 20844610
[TBL] [Abstract][Full Text] [Related]
38. Successful management of portopulmonary hypertension with beraprost.
Kim EJ; Shin MS; Oh KY; Kim MG; Shin KC; Park YM; Kim BR; Chung WJ; Ahn TH; Choi IS; Shin EK
Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1503-5. PubMed ID: 21389799
[TBL] [Abstract][Full Text] [Related]
39. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
40. Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids.
Hoeper MM; Taha N; Bekjarova A; Gatzke R; Spiekerkoetter E
Eur Respir J; 2003 Aug; 22(2):330-4. PubMed ID: 12952269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
